These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 16488571

  • 1. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
    Christopoulou GE, Stavropoulou A, Anastassopoulos G, Panteliou SD, Papadaki E, Karamanos NK, Panagiotopoulos E.
    J Pharm Biomed Anal; 2006 Jun 07; 41(3):891-7. PubMed ID: 16488571
    [Abstract] [Full Text] [Related]

  • 2. Vibrational bone characteristics versus bone density for the assessment of osteoporosis in ovariectomized rats.
    Anastassopoulos G, Panteliou S, Christopoulou G, Stavropoulou A, Panagiotopoulos E, Lyritis G, Khaldi L, Varakis J, Karamanos N.
    J Med Eng Technol; 2010 Jan 07; 34(1):35-42. PubMed ID: 19995148
    [Abstract] [Full Text] [Related]

  • 3. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
    Perifanis V, Vyzantiadis T, Tziomalos K, Vakalopoulou S, Garipidou V, Athanassiou-Metaxa M, Harsoulis F.
    Ann Hematol; 2007 Jan 07; 86(1):23-30. PubMed ID: 17013645
    [Abstract] [Full Text] [Related]

  • 4. Alteration in serum leptin correlates with alterations in serum N-telopeptide of collagen type I and serum osteocalcin during the progression of osteoporosis in ovariectomized rats.
    Stavropoulou A, Christopoulou GE, Anastassopoulos G, Panteliou SD, Lyritis GP, Spiliotis BE, Karamanos NK, Panagiotopoulos E, Lambiris E.
    Clin Chem Lab Med; 2005 Jan 07; 43(12):1359-65. PubMed ID: 16309373
    [Abstract] [Full Text] [Related]

  • 5. [Prediction of changes in bone density during alendronate treatment in postmenopausal women].
    Masaryk P, Stancíková M, Letkovská A, Rovenský J.
    Vnitr Lek; 2002 Oct 07; 48(10):943-7. PubMed ID: 16737141
    [Abstract] [Full Text] [Related]

  • 6. Onion decreases the ovariectomy-induced osteopenia in young adult rats.
    Huang TH, Mühlbauer RC, Tang CH, Chen HI, Chang GL, Huang YW, Lai YT, Lin HS, Yang WT, Yang RS.
    Bone; 2008 Jun 07; 42(6):1154-63. PubMed ID: 18387868
    [Abstract] [Full Text] [Related]

  • 7. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA, Ingold P, Venturiere A, Shen V, Green JR.
    J Bone Miner Res; 2008 Apr 07; 23(4):544-51. PubMed ID: 18072878
    [Abstract] [Full Text] [Related]

  • 8. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    J Bone Miner Metab; 2005 Apr 07; 23(3):238-42. PubMed ID: 15838627
    [Abstract] [Full Text] [Related]

  • 9. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E.
    Scand J Gastroenterol; 2003 Mar 07; 38(3):320-7. PubMed ID: 12737449
    [Abstract] [Full Text] [Related]

  • 10. A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat.
    Cho DC, Kim KT, Jeon Y, Sung JK.
    Acta Neurochir (Wien); 2012 Dec 07; 154(12):2215-23. PubMed ID: 23053289
    [Abstract] [Full Text] [Related]

  • 11. Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis.
    Papadaki HA, Tsatsanis C, Christoforidou A, Malliaraki N, Psyllaki M, Pontikoglou C, Miliaki M, Margioris AN, Eliopoulos GD.
    J Bone Miner Metab; 2004 Dec 07; 22(6):577-87. PubMed ID: 15490268
    [Abstract] [Full Text] [Related]

  • 12. Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis.
    Gur A, Colpan L, Cevik R, Nas K, Jale Sarac A.
    Clin Biochem; 2005 Jan 07; 38(1):66-72. PubMed ID: 15607319
    [Abstract] [Full Text] [Related]

  • 13. Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy.
    Greenspan SL, Holland S, Maitland-Ramsey L, Poku M, Freeman A, Yuan W, Kher U, Gertz B.
    Proc Assoc Am Physicians; 1996 May 07; 108(3):230-8. PubMed ID: 8774056
    [Abstract] [Full Text] [Related]

  • 14. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D.
    Anticancer Res; 2007 May 07; 27(4A):1853-62. PubMed ID: 17649784
    [Abstract] [Full Text] [Related]

  • 15. Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model.
    Rissanen JP, Suominen MI, Peng Z, Morko J, Rasi S, Risteli J, Halleen JM.
    Calcif Tissue Int; 2008 Feb 07; 82(2):155-61. PubMed ID: 18219436
    [Abstract] [Full Text] [Related]

  • 16. Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus.
    Pivonello R, Faggiano A, Di Somma C, Klain M, Filippella M, Salvatore M, Lombardi G, Colao A.
    J Clin Endocrinol Metab; 1999 Jul 07; 84(7):2349-52. PubMed ID: 10404801
    [Abstract] [Full Text] [Related]

  • 17. Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate.
    Muñoz-Torres M, Reyes-García R, Mezquita-Raya P, Fernández-García D, Alonso G, Luna Jde D, Ruiz-Requena ME, Escobar-Jiménez F.
    Maturitas; 2009 Nov 20; 64(3):188-92. PubMed ID: 19819089
    [Abstract] [Full Text] [Related]

  • 18. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
    Elwakkad AS, El Elshamy KA, Sibaii H.
    Epilepsy Res; 2008 Jul 20; 80(1):47-56. PubMed ID: 18455911
    [Abstract] [Full Text] [Related]

  • 19. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat.
    Wezeman FH, Emanuele MA, Moskal SF, Steiner J, Lapaglia N.
    J Bone Miner Res; 2000 Oct 20; 15(10):2033-41. PubMed ID: 11028458
    [Abstract] [Full Text] [Related]

  • 20. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K.
    Bone; 2008 Nov 20; 43(5):894-900. PubMed ID: 18687415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.